Exelixis, Inc.
Nasdaq · Healthcare · Biological Products, (No Diagnostic Substances) · Alameda, CA
EXEL chart
What traders are saying about $EXEL
Latest postsExelixis, Inc. news
- Exelixis stock hits all-time high at 65.62 USD
Investing.com ·
- Bank of America keeps USD 41 target for Exelixis stock
ad-hoc-news.de ·
- Exelixis, Inc. (EXEL) Stock Price, News, Quote & History
Yahoo! Finance Canada ·
- IDEAYA Biosciences, Inc. (IDYA) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Yahoo Finance ·
- Exelixis Inc. Common Stock (EXEL) Financial Statements
Pluang ·
- What Exelixis Shareholders Got Right
Simply Wall Street ·
- Exelixis, Inc. (NASDAQ:EXEL) Rises 0.90% to USD 65.11 as RSI(14) Moves Above 70 Alongside 52.70% EPS Growth
Kalkine India ·
- Bristol Myers Squibb's Cancer Breakthrough Could Have Implications Beyond Its Own Stock
marketbeat.com ·
- Exelixis (EXEL) Faces An FDA Delay, Is The Stock Fully Valued?
Simply Wall Street ·
- Exelixis (NasdaqGS:EXEL) Stock Forecast & Analyst Predictions
Simply Wall Street ·
- Forget the FDA Delay: 3 Reasons Exelixis Is Still a Buy
fool.com ·
- RBC raises target for Exelixis stock from USD 45 to USD 51
ad-hoc-news.de ·
Exelixis, Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Revenue | $2.32B | $2.17B | $1.83B | $1.61B |
| Net income | $782.6M | $521.3M | $207.8M | $182.3M |
| Diluted EPS | $2.78 | $1.76 | $0.65 | $0.56 |
| Total assets (year end) | $2.84B | $2.95B | $2.94B | $3.07B |
| Cash and equivalents (year end) | $482.5M | $217.4M | $263.0M | $501.2M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Exelixis, Inc.
- Ticker
- EXEL (Nasdaq)
- Industry
- Biological Products, (No Diagnostic Substances)
- Headquarters
- Alameda, CA
- Incorporated in
- DE
- Fiscal year end
- January 1
- SEC CIK
- 939767
- Former names
- EXELIXIS INC
Frequently asked questions
What exchange is Exelixis, Inc. listed on?
Exelixis, Inc. trades on the Nasdaq under the ticker symbol EXEL.
What industry is Exelixis, Inc. in?
Exelixis, Inc. is classified by the SEC under "Biological Products, (No Diagnostic Substances)", part of the Healthcare sector on StockTweeting.
Where is Exelixis, Inc. headquartered?
Exelixis, Inc.'s business address on file with the SEC is in Alameda, CA.
When does Exelixis, Inc.'s fiscal year end?
Exelixis, Inc.'s fiscal year ends on January 1.
How much revenue did Exelixis, Inc. report?
Exelixis, Inc. reported $2.32B in revenue for calendar year 2025, according to its SEC filings.